RYAN AGOSTINELLI: Open Payments
NPI 1043763253 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 46 payments from 13 companies in 2025. Trend: 2023 $608 · 2024 $897 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $336 |
| ABBVIE INC. | 11 | $227 |
| Corcept Therapeutics | 5 | $133 |
| Exact Sciences Corporation | 4 | $86 |
| PFIZER INC. | 3 | $78 |
| Kowa Pharmaceuticals America, Inc. | 4 | $60 |
| Lilly USA, LLC | 1 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: Ozempic, UBRELVY, Korlym, Wegovy, NURTEC ODT, The Cologuard Plus Collection Kit, ZORYVE, VRAYLAR.
Industry payments across WA — which companies pay providers there.
